INTRODUCTION
============

A variety of growth factors, including transforming growth factor β (TGF-β), can induce epithelial cells to undergo the transdifferentiation process of epithelial--mesenchymal transition (EMT). Although EMT occurs normally in development and wound healing, it can also contribute to pathological processes such as fibrosis and cancer progression ([@B29]). During EMT, cellular junctions are disassembled and remodeled in concert with cytoskeletal alterations and acquisition of a mesenchymal phenotype ([@B25]). Gap junctions, composed of connexin proteins, provide direct intercellular communication between polarized epithelial cells and are subject to down-regulation with loss of polarity during EMT ([@B18]; [@B3]). Of the 21 human connexins, connexin43 (Cx43; gene name *GJA1*) is the most ubiquitously expressed gap junction protein ([@B4]). A rate-limiting step in Cx43 intracellular transport occurs at the *trans*-Golgi network (TGN) where six Cx43 monomers must oligomerize to form Cx43 hemichannels, or connexons, to permit cytoskeleton-based trafficking to the plasma membrane ([@B70]). Connexons on the surface of apposing cells dock to form continuous channels which coalesce into dense arrays, termed gap junction plaques, to effect direct intercellular flow of ions and small molecules ([@B27]). Suppression of gap junctional intercellular coupling (GJIC) was thought to be a necessary step for EMT progression as cells become migratory; however, involvement of Cx43 in critical cellular processes including cell migration and cell cycle regulation implicate a more complex role for this protein during EMT ([@B30]; [@B35]; [@B21]; [@B47]).

Investigation of the molecular mechanisms governing EMT has focused on induction of transcriptional programs and posttranslational modifications. Translation, however, is gaining increasing appreciation as a dynamic regulator of the proteome during cellular processes including EMT ([@B66]; [@B33]). Translation of Cx43 can be regulated at the RNA level during development, demonstrated in mice through alternative splicing and alternative promoter usage within its 5′ untranslated region (5′ UTR; [@B44]). This process is further complicated by the existence of an internal ribosome entry site (IRES) within the *GJA1* 5′ UTR, and the recent finding that the coding sequence of *GJA1* is also subject to internal translation initiation events to yield N-terminally truncated Cx43 isoforms ([@B53]; [@B58]; [@B51]; [@B68]). Alternative modes of translation initiation such as internal translation are historically recognized as a mechanism used by viruses to increase their protein coding capacity ([@B38]). More recently, alternative translation has been recognized to occur in eukaryotes, playing a role in the biological programs of apoptosis, differentiation, and metastasis ([@B62]; [@B37]). High-throughput experiments in mammalian cells have suggested a prominent role for alternative translation in modulating protein diversity, and genome-wide analysis of translation initiation sites using ribosome profiling identified a substantial degree of novel and "noncanonical" translation initiation start sites ([@B23]; [@B46]; [@B71]). These sites can generate N-terminal truncations of proteins as is found with *GJA1*, upstream open reading frames, or alternate reading frames ([@B23]).

The most predominantly expressed N-terminally truncated Cx43 isoform is termed GJA1-20k, with full-length Cx43 termed GJA1-43k ([@B58]; [@B51]; [@B68]). Importantly, GJA1-20k is understood to reside at intracellular structures including the endoplasmic reticulum (ER) and Golgi apparatus and has been demonstrated to regulate Cx43 gap junction formation. Limiting the cell's ability to express GJA1-20k results in distribution of Cx43 throughout the cytosol and loss of gap junctions at cell borders ([@B58]). In cardiac cells, ectopic expression of GJA1-20k induces actin stabilization and promotes gap junction formation at intercalated discs, revealing therapeutic potential in restoring gap junction coupling during ischemia ([@B1]). More recently, studies have also localized GJA1-20k to mitochondria where a protective role in mitochondrial dynamics and integrity was identified ([@B16]). Levels of GJA1-20k are responsive to cellular stress such as hypoxia and simulated ischemia, and alteration of *GJA1* mRNA internal translation can be regulated by signal transduction pathways including PI3K/Akt/mTOR and Mnk1/2 ([@B58]; [@B68]). TGF-β induces EMT through both Smad and nonSmad signaling ([@B17]). One way that TGF-β signaling contributes to EMT is through activation of the PI3K/Akt/mTOR pathway, an important regulator of protein translation and GJA1-20k synthesis ([@B8]; [@B58]; [@B29]). We therefore hypothesized that alterations in translation initiation could contribute to changes in gap junction formation during EMT, independent of posttranslational or transcriptional regulation.

RESULTS
=======

Internal translation of *Gja1* is suppressed during TGF-β--induced EMT
----------------------------------------------------------------------

To investigate the contribution of internal translation initiation in EMT-associated alterations in Cx43 gap junctions, we utilized normal mouse mammary gland epithelial cells (NMuMG). NMuMG cells are an established cell model which readily undergoes EMT upon stimulation with TGF-β ([@B45]). Expression of mesenchymal markers including fibronectin and N-cadherin with concomitant suppression of the epithelial marker E-cadherin were detected by Western blot, reverse transcription quantitative PCR (RT-qPCR), and immunofluorescence, confirming induction of the EMT process within 24 h of TGF-β addition (Supplemental Figure 1). Phase contrast microscopy reveals morphological changes from an epithelial "cobblestone" phenotype to larger spindle-shaped mesenchymal cells by 48 h after TGF-β stimulation ([Figure 1A](#F1){ref-type="fig"}). Given the role of PI3K/AKT/mTOR in TGF-β--induced EMT, and in regulation of GJA1-20k translation ([@B58]), we investigated the status of *Gja1* translation by Western blot. Cx43 was detected with an antibody directed against the C-terminus, capable of detecting GJA1-20k and its full-length counterpart GJA1-43k. We find significantly increased levels of GJA1-43k in mesenchymal cells in comparison to controls treated only with vehicle ([Figure 1B](#F1){ref-type="fig"}). GJA1-20k levels, however, are significantly reduced relative to GJA1-43k ([Figure 1](#F1){ref-type="fig"}, B, quantified in C). To ask whether increased GJA1-20k protein degradation is responsible, we used replication incompetent lentiviruses to generate stable cell lines encoding *LacZ*, the entire *GJA1* coding sequence, or GJA1-20k alone. Again, levels of GJA1-43k were increased and relative levels of GJA1-20k reduced following stimulation with TGF-β in *LacZ* and *GJA1* cell lines. The GJA1-20k stable cells, however, maintained GJA1-20k expression following stimulation with TGF-β, where the protein is constitutively synthesized from an independent mRNA and therefore not subject to suppression of internal translation ([Figure 1](#F1){ref-type="fig"}, D, quantified in E). These data demonstrate that altered GJA1-43k and GJA1-20k levels in mesenchymal cells are likely not due to increased degradation of GJA1-20k, but rather inhibition of translation initiation within *GJA1* mRNA with concomitant enhanced GJA1-43k translation from the initial start codon. Specificity to TGF-β signaling is confirmed with the TGF-β receptor inhibitor SB431542, which inhibits EMT induction and rescues expression of GJA1-20k. Together, these data suggest a shift in translation initiation may occur during EMT to regulate Cx43 localization and function at the posttranscriptional level.

GJA1-43k protein localizes to nonjunctional soluble pools during TGF-β--induced EMT
-----------------------------------------------------------------------------------

Dissolution of intercellular junctions is an established hallmark of EMT, yet conflicting reports exist regarding the fate of Cx43 as cells acquire the mesenchymal phenotype ([@B69]; [@B11]; [@B64]; [@B3]; [@B20]). Our finding that GJA1-20k, which is known to regulate gap junction formation, occurs at lower levels in mesenchymal cells ([Figure 1](#F1){ref-type="fig"}), would suggest alterations in GJA1-43k intracellular trafficking. Immunofluorescence confocal microscopy reveals diffuse redistribution of Cx43 to the cytosol during EMT ([Figure 2](#F2){ref-type="fig"}A). Cx43 gap junctions still occur at cell--cell borders in mesenchymal cells, but are fewer and more punctate than those of epithelial cells. To complement immunofluorescence studies, we employed the Triton X-100 solubility assay to fractionate and quantify junctional GJA1-43k in mesenchymal cells and their unstimulated epithelial counterparts at 48 h after induction. Consistent with our immunofluorescence data, significantly lower levels of junctional Cx43 were detected following TGF-β stimulation relative to total Cx43 ([Figure 2](#F2){ref-type="fig"}, B, quantified in C). Together, these data demonstrate limited gap junction formation in mesenchymal cells despite increased Cx43 protein levels.

![TGF-β treatment induces EMT and suppresses internal translation of *Gja1* mRNA. NMuMG cells were treated with 2 ng/ml TGF-β for 48 h to induce EMT. (A) Phase contrast microscopy of NMuMG cells ×20. (B) Western blot of cell lysates probed with Cx43 C-terminal antibody to detect full-length GJA1-43k and internally translated GJA1-20k. α-Tubulin serves as loading control. (C) Quantification of GJA1-20k band intensity relative to GJA1-43k from B. (D) Stable pools of NMuMG cells transduced with pLenti6.3-*LacZ*, pLenti6.3-*GJA1*, or pLenti6.3-GJA1-20k were treated with vehicle, 2 ng/ml TGF-β, 5 μM SB431542, or TGF-β + SB431542 for 48 h. Western blot of cell lysates probed with Cx43 C-terminal antibody to detect full-length GJA1-43k and GJA1-20k. Arrows indicate TGF-β treated samples; GAPDH serves as loading control. (E) Quantification of GJA1-20k band intensity relative to GJA1-43k from D. Graphs represent mean ± SEM. Statistical analysis performed using the Student's *t* test (C, *n* = 3) and one-way analysis of variance (ANOVA) with Tukey's multiple comparison posttest (E, *n* = 3). \**p* ≤ 0.05.](mbc-29-797-g001){#F1}

![Cytosolic enrichment of Cx43 occurs during TGF-β--induced EMT. NMuMG cells were treated with 2 ng/ml TGF-β for 48 h to induce EMT before fixation for immunofluorescence analysis or protein harvesting for solubility assay and Western blot. (A) Fixed cell confocal immunofluorescence (×100) of cells labeled with an antibody directed against the Cx43 C-terminus (green) with borders detected using E-cadherin in vehicle-treated cells (red) and N-cadherin in TGF-β--treated cells (red). Cx43 depicted in white in monochrome images with zoom of cell border shown below. Nuclei counterstained with DAPI (blue). Scale bar: 20 μm. (B) Western blots of total, soluble (nonjunctional), and insoluble (junctional) GJA1-43k following fractionation using the 1% Triton X-100 solubility assay. (C) Quantification of insoluble (junctional) GJA1-43k band intensity relative to soluble (nonjunctional) GJA1-43k from B (*n* = 3). Graphs represent mean ± SEM. Statistical analysis performed using the Student's *t* test. \**p* ≤ 0.05.](mbc-29-797-g002){#F2}

Levels of GJA1-43k protein and *Gja1* transcript increase during TGF-β--induced EMT and GJA1-43k protein is stabilized
----------------------------------------------------------------------------------------------------------------------

In Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} we report that TGF-β stimulation increases GJA1-43k levels in concert with reduced GJA1-20k expression and redistributes GJA1-43k to nonjunctional compartments. Interestingly, total levels of GJA1-43k protein increase significantly over the 72 h time course of EMT induction ([Figure 3](#F3){ref-type="fig"}, A, quantified in B). We also find by RT-qPCR that *Gja1* mRNA increased continuously throughout the 72 h time course ([Figure 3](#F3){ref-type="fig"}C). These findings led us to investigate changes in Cx43 protein regulation, where altered GJA1-43k stability could explain the lack of correlation between protein and mRNA levels, and gap junction formation. Click chemistry was utilized to perform nonradioactive pulse-chase experiments to determine GJA1-43k stability in the presence of TGF-β stimulation ([@B5]). We find that despite reduced gap junction formation, GJA1-43k half-life increased from 1.3 h in unstimulated cells to 2 h following 48 h TGF-β stimulation ([Figure 3](#F3){ref-type="fig"}, D, quantified in E).

![Levels of GJA1-43k protein and *Gja1* transcript increase during TGF-β--induced EMT and GJA1-43k is stabilized. NMuMG cells were treated with vehicle, 2 ng/ml TGF-β, 5 μM SB431542 (SB), or TGF-β + SB431542 and sampled at 24, 48, and 72 h after stimulation for Western blot and RT-qPCR. (A) Western blot of GJA1-43k in NMuMG cells after treatment (left panels) with α-tubulin serving as loading control (right panels). (B) Quantification of GJA1-43k band intensity relative to α-tubulin from A. (C) qRT-PCR of *Gja1* mRNA levels after treatment relative to vehicle at 24, 48, and 72 h after treatment (*n* = 6). (D) Western blot of total GJA1-43k and TAMRA pulsed GJA1-43k in NMuMG cells following 48 h treatment with vehicle or TGF-β. Time points indicate hours after pulse with TAMRA alkyne. (E) GJA1-43k exponential decay curves of blots described in E; vehicle *t*~1/2~ = 1.3 h, TGF-β *t*~1/2~ = 2.0 h (*n* = 3). Graphs represent mean ± SEM. Statistical analysis performed using one-way ANOVA with Tukey's multiple comparison posttest (B, *n* = 3; C, *n* = 5). \**p* ≤ 0.05; \*\**p* ≤ 0.01.](mbc-29-797-g003){#F3}

Ectopic stable expression of GJA1-20k rescues gap junction formation and does not alter EMT marker induction in NMuMG cells
---------------------------------------------------------------------------------------------------------------------------

Having demonstrated that internal translation of GJA1-20k is suppressed during EMT, we next removed cellular control of GJA1-20k expression in order to test the necessity of GJA1-20k suppression for gap junction down-regulation. Utilizing lentivirally transduced clonal NMuMG cell lines expressing *LacZ* as control or the GJA1-20k coding sequence, we find that both *LacZ* and GJA1-20k cell lines underwent EMT following TGF-β stimulation. Both cell lines displayed comparable morphological changes by phase contrast microscopy ([Figure 4](#F4){ref-type="fig"}A) and immunofluorescence confocal imaging reveals comparable fibronectin (green) induction with actin (red) stress-fiber formation in mesenchymal cells ([Figure 4](#F4){ref-type="fig"}B). Induction of EMT markers fibronectin and N-cadherin was confirmed biochemically by Western blot ([Figure 4](#F4){ref-type="fig"}, C, quantified in D). To determine effects on GJA1-43k subcellular localization and gap junction formation, confocal immunofluorescence microscopy was employed ([Figure 5](#F5){ref-type="fig"}, A--D). We detected GJA1-43k using an antibody targeting the cytoplasmic loop of Cx43, in order to exclude a confounding signal from truncated Cx43 isoforms. To measure changes in GJA1-43k gap junction formation and subcellular distribution, quantification was performed by fluorescence intensity line scans across cell borders ([Figure 5](#F5){ref-type="fig"}, B and D; [@B59]). Cell borders are identified with a pan-cadherin antibody (red). Upon TGF-β stimulation, GJA1-20k cells are protected against cytosolic redistribution of Cx43 and gap junctions are maintained with practically no change in intensity profiles detected ([Figure 5](#F5){ref-type="fig"}, C and D), despite comparable increases in GJA1-43k to *LacZ* cells ([Figure 1, D and E](#F1){ref-type="fig"}). To complement immunofluorescence studies, we again employed the Triton X-100 solubility assay to fractionate and quantify junctional GJA1-43k relative to nonjunctional protein 48 h after EMT induction in cell lines expressing *LacZ* or GJA1-20k. Consistent with our immunofluorescence data, significantly lower levels of junctional Cx43 occur following TGF-β stimulation in cells expressing *LacZ*, while cells expressing GJA1-20k maintained junctional Cx43 during EMT ([Figure 5](#F5){ref-type="fig"}, E, quantified in F). These data demonstrate that suppression of GJA1-20k translation has no apparent effect on EMT induction, but is necessary for limiting gap junction formation in mesenchymal cells.

![NMuMG cells transduced with pLenti6.3-*LacZ* or pLenti6.3-GJA1-20k undergo EMT. Stable NMuMG cells transduced with pLenti6.3-*LacZ* or pLenti6.3-GJA1-20k were treated with vehicle, 2 ng/ml TGF-β, 5 μM SB431542 (SB), or TGF-β + SB431542 for 48 h. (A) Phase contrast microscopy at 48 h after stimulation, ×20. Scale bar: 100 μm. (B) Fixed cell confocal immunofluorescence (×100) of cells labeled with antibody directed against EMT markers actin (red) and fibronectin (green). Nuclei counterstained with DAPI (blue). Scale bar: 20 μm. (C) Western blot probed for EMT markers fibronectin and N-cadherin with α-tubulin serving as loading control. (D) Quantification of Western blot band intensity in C. Graphs represent mean ± SEM. Statistical analysis performed using one-way ANOVA with Tukey's multiple comparison posttest (*n* = 3). ns: *p* value not significant.](mbc-29-797-g004){#F4}

![Ectopic stable expression of GJA1-20k rescues gap junction loss during TGF-β--induced EMT. Stable NMuMG cells were treated with vehicle or TGF-β for 48 h and subsequently fixed for confocal immunofluorescence imaging. (A) Cells stably expressing pLenti6.3-*LacZ* labeled for GJA1-43k with antibody directed against the Cx43 cytoplasmic loop (green) to prevent labeling for GJA1-20k. Cell borders are identified with pan-cadherin (red) and nuclei counterstained with DAPI (blue). (B) Quantification of average fluorescence intensity profiles of 7-μm lines bisecting, and perpendicular to, cell--cell borders from confocal microscopy maximum intensity projections. Three cell--cell borders per image, *n* = 11 images. (C) Cells stably expressing pLenti6.3-GJA1-20k labeled for GJA1-43k with antibody directed against the Cx43 cytoplasmic loop (green). Cell borders are identified with pan-cadherin (red) and nuclei counterstained with DAPI. (D) Quantification of average fluorescence intensity profiles as in B. (E) Western blots of total (T), soluble (S; nonjunctional), and insoluble (I; junctional) GJA1-43k following fractionation using the 1% Triton X-100 solubility assay in NMuMG cells transduced with pLenti6.3-LacZ or pLenti6.3-GJA1-20k. Cells were treated with vehicle or TGF-β for 48 h. (F) Quantification of insoluble (junctional) GJA1-43k band intensity relative to soluble (nonjunctional) GJA1-43k from E (*n* = 5). Graphs represent mean ± SEM. Statistical analysis performed using the Student's *t* test. \**p* ≤ 0.05; \*\*\*\**p* ≤ 0.0001.](mbc-29-797-g005){#F5}

GJA1-20k localizes to the Golgi apparatus and regulates Cx43 hemichannel oligomerization
----------------------------------------------------------------------------------------

Given that GJA1-20k is known to play a role in GJA1-43k trafficking, we investigated localization of GJA1-20k/GJA1-43k within subcellular compartments of the vesicular transport pathway. Confocal immunofluorescence microscopy revealed colocalization of V5-epitope tagged GJA1-20k with the Golgi apparatus marker GM130 ([Figure 6](#F6){ref-type="fig"}A). Direct stochastic optical reconstruction microscopy (STORM) was employed to localize the Golgi apparatus (GM130) at subdiffraction limit resolution with GJA1-43k in cells stably expressing *LacZ* or GJA1-20k ([Figure 6](#F6){ref-type="fig"}, B--E). Cross-pair correlation generates a probability distribution of finding a given molecule as a function of a given distance from another distinct molecule, with a pair correlation amplitude of 1 indicating no colocalization between two proteins and higher values indicating a correlation. Utilizing an antibody directed against the Cx43 cytoplasmic loop, pair correlation analysis reveals an increase in GJA1-43k colocalization with GM130 following TGF-β stimulation in cells expressing *LacZ*, suggesting retention of GJA1-43k in the Golgi apparatus ([Figure 6](#F6){ref-type="fig"}C). In cells expressing GJA1-20k, however, GJA1-43k colocalization with GM130 remains comparable to that in vehicle-treated cells ([Figure 6](#F6){ref-type="fig"}E). GJA1-43k oligomerization into hexamers at the TGN is a rate-limiting step in Cx43 trafficking ([@B41]). Given our GJA1-43k and GJA1-20k localization data, we hypothesized a role for GJA1-20k in promoting hemichannel formation, thereby enhancing Golgi exit, transport, and Cx43 gap junction formation during TGF-β stimulation. We turned to nondenaturing blue NativePAGE gel electrophoresis and quantified the ratio of hexameric (∼258 kDa) versus monomeric (43 kDa) Cx43 in cell lines stably expressing *LacZ* or GJA1-20k, with and without TGF-β stimulation ([Figure 6](#F6){ref-type="fig"}, F, quantified in G). Quantification of band intensity by densitometry reveals a modest increase in hexamer formation in *LacZ* cells following EMT induction. GJA1-20k cells, however, display significantly larger increases in hexamer formation than that observed in *LacZ* control cells ([Figure 6](#F6){ref-type="fig"}G).

![GJA1-20k promotes GJA1-43k oligomerization and release from the Golgi apparatus. NMuMG cells were transfected with C-terminally V5 tagged GJA1-20k and subsequently fixed for confocal immunofluorescence imaging. (A) Fixed cell confocal immunofluorescence (×100) of NMuMG cells 24 h posttransfection. The Golgi apparatus is labeled with an antibody directed against GM130 (green) and GJA1-20k detected with antibody directed against the V5 epitope tag (red). (B, D) Stable NMuMG cells transduced with pLenti6.3-LacZ or pLenti6.3-GJA1-20k were treated with vehicle or TGF-β for 48 h and subsequently fixed for superresolution immunofluorescence imaging. 3D STORM imaging detecting GJA1-43k (green) and GM130 (pink) with localizations depicted as 50-nm point clouds in an *x-y* cross-section. Scale bars: 2 µm. (C, E) Cross-pair correlation functions for GJA1-43k and GM130 from stable NMuMG cells treated with vehicle (black) or TGF-β (red). Graphs represent mean ± SEM, *n* = 10 cells. (F) Western blot of blue NativePAGE probed for Cx43 hexamers (∼258 kDa) and monomers (∼43 kDa). (G) Quantification of Western blot band intensity in F (*n* = 5). Graphs represent mean ± SEM. Statistical analysis performed using the Student's *t* test. \**p* ≤ 0.05; \*\**p* ≤ 0.01.](mbc-29-797-g006){#F6}

Smad3 and ERK1/2 activity are necessary to suppress internal translation of *GJA1* mRNA during TGF-β stimulation
----------------------------------------------------------------------------------------------------------------

To determine which pathway(s) activated by TGF-β regulate the balance between GJA1-20k and GJA1-43k, we employed chemical inhibitors targeting protein kinases downstream from TGF-β signaling. We then measured the ratio of GJA1-20k/GJA1-43k by Western blot after 24 h of inhibitor treatment with or without the addition of TGF-β. Canonical TGF-β signaling involves activation of Smad transcription factors in order to modulate gene expression. We used the chemical inhibitor SIS3 to inhibit phosphorylation of the receptor Smad, Smad3 ([@B24]), to ask whether Smad signaling was necessary to suppress internal translation of GJA1-20k. Incubation with SIS3 combined with TGF-β treatment resulted in a significantly larger ratio of GJA1-20k/GJA1-43k compared with TGF-β treatment alone. This confirms a role for this arm of TGF-β signaling in altered translation initiation. TGF-β signaling also activates ERK1/2 independent of Smad-induced transcriptional modulation. We inhibited the map kinases ERK1/2 with the chemical inhibitor SCH 772984 and found a greater than ninefold increase in the ratio of GJA1-20k/GJA1-43k compared with vehicle. When ERK1/2 inhibition is combined with TGF-β treatment there is a significantly larger ratio of GJA1-20k/GJA1-43k compared with TGF-β treatment alone. In addition, both p38 MAPK and JNK are activated by TGF-β in a Smad-independent manner. We employed the chemical inhibitors SB 202190 and SP 600125 to inhibit p38 and JNK, respectively. Neither p38 nor JNK inhibition combined with TGF-β has a significant effect on the ratio of GJA1-20k/GJA1-43k when compared with TGF-β treatment alone ([Figure 7](#F7){ref-type="fig"}, A, quantified in B). Together, these findings confirm a role for internal translation of *GJA1* mRNA in regulation of full-length Cx43 (GJA1-43k) isoform transport and oligomerization, therefore controlling trafficking and gap junction formation at the posttranscriptional stage ([Figure 7](#F7){ref-type="fig"}C).

![TGF-β activates Smad and ERK signaling to alter translation initiation and limit gap junction formation during EMT. NMuMG cells were treated with vehicle (veh; DMSO), 10 µM SIS3, 20 µM SB 202190 (SB2), 20 µM SP 600125 (SP6), or 0.1 µM SCH 772984 (SCH), for 15 min followed by the addition of 2 ng/ml TGF-β for 24 h. (A) Western blot of cell lysates probed with Cx43 C-terminal antibody to detect full-length GJA1-43k and internally translated GJA1-20k. (B) Quantification of GJA1-20k band intensity relative to GJA1-43k from A. (C) Schematic illustrating suppression of GJA1-20k translation during TGF-β--induced EMT to limit GJA1-43k oligomerization and gap junction formation. Graph represents mean ± SEM. Statistical analysis performed using one-way ANOVA with Dunnett's multiple comparison posttest (B, *n* = 5--7). \*\*\**p* ≤ 0.0005; \*\*\*\**p* ≤ 0.0001.](mbc-29-797-g007){#F7}

DISCUSSION
==========

Research on Cx43 and gap junction regulation has historically focused upon transcription, trafficking, and posttranslational modification of the full-length GJA1-43k protein. The existence of an IRES within the 5′ UTR of *GJA1* mRNA, together with the recent finding by several groups that *GJA1* mRNA can undergo internal translation, has highlighted translation initiation as a novel and key regulatory step in Cx43 gap junction regulation ([@B53]; [@B58]). Internal translation of *GJA1* mRNA yields N-terminally truncated isoforms, including GJA1-20k, and their expression influences GJA1-43k localization and gap junction formation. However, implementation of this dynamic translational regulation by the cell in gap junction formation and maintenance has yet to be demonstrated. We utilized EMT as a physiologically relevant model system with which to investigate the role of internal translation and GJA1-20k on GJA1-43k gap junction formation and maintenance. The process of EMT involves reorganization of intercellular junctional structures as cells acquire mesenchymal traits ([@B29]). As the primary means of direct intercellular communication, gap junctions undergo significant remodeling during this process ([@B39]; [@B3]). In this study, we report that suppression of *Gja1* mRNA internal translation in mesenchymal cells is sufficient to limit gap junction formation.

Although the loss of adherens and tight junctions during EMT has been well documented, data regarding the effects of TGF-β on *GJA1* transcription and Cx43 protein levels are conflicting ([@B31]; [@B69]; [@B11]; [@B64]; [@B20]; [@B6]). Electrical conduction between epicardial cells is decreased significantly during and after EMT, coincident with decreased expression of Cx43 as well as other gap junction proteins ([@B3]). EMT induction in human kidney cells also results in decreased GJIC, and again results in decreased Cx43 expression as cells become mesenchymal ([@B20]). Overexpression of Cx43 in glioma and breast cancer cells results in an epithelial morphology, supporting a role of Cx43 and gap junctions in maintaining an epithelial phenotype ([@B22]; [@B39]). Tumor-suppressive properties of Cx43 have been documented in a number of contexts beyond EMT, and Cx43 expression is down-regulated in many human cancers ([@B65]; [@B28]; [@B56]). Ectopic expression of Cx43 in colon cancer epithelial cells does not appear to form gap junctions but limits cancer cell growth by antagonizing apoptotic pathways ([@B56]). In contrast, other studies have reported induction of Cx43 expression during EMT and associated high levels of Cx43 with more invasive and migratory cells ([@B31]; [@B2]; [@B64]; [@B76]). Finally, overexpression of connexins has been associated with inhibition of EMT in hepatocellular and lung carcinoma cell populations resistant to chemotherapeutic agents ([@B75], [@B74]). Together with our work revealing lack of correlation between Cx43 protein, RNA levels, and gap junction formation, this highlights the complexity of connexin biology during EMT progression and the contribution of translational regulation.

Based on our data, the question remains as to why mesenchymal cells must harbor such high levels of intracellular GJA1-43k relative to gap junctional GJA1-43k. Interestingly, we did not observe complete gap junction dissolution in mesenchymal cells, although gap junctions were less dense and more punctate than in epithelial cells. Nonchannel/junctional functions for Cx43 have been reported where intracellular localization is sufficient to negatively regulate cell cycle progression and participate in cytoskeleton nucleation ([@B42]; [@B7]). Indeed, cell proliferation is suppressed during TGF-β--induced EMT, and intracellular GJA1-43k may play a role here ([@B49]). The existence of internally translated Cx43 isoforms which encompass the C-terminus further complicates interrogation of this biology, as many nonjunctional functions of Cx43 have been attributed its C-terminus. The Cx43 C-terminus alone is sufficient to restore actin-mediated B-cell spreading and adhesion, and the cytoskeleton plays an essential role in migration of mesenchymal cells ([@B73]; [@B36]). In addition to intercellular communication, gap junction maintenance may assist in cell migration where the adhesive properties of gap junction channels have previously been shown as necessary for cell motility ([@B13]; [@B35]). Importantly, such high levels of intracellular GJA1-43k demonstrate that transport is not constitutive and that a posttranscriptional mechanism is therefore in place to limit gap junction formation irrespective of GJA1-43k protein levels.

Activation of the Smad-independent mTOR pathway is known to suppress internal translation of the *GJA1* transcript ([@B58]). In this study, we investigated pathways upstream and independent of mTOR. The TGF-β receptor rapidly activates ERK1/2 signaling through recruitment and phosphorylation of ShcA ([@B32]). TGF-β also activates TAK1, independent of its receptor kinase activity, leading to activation of the MAP kinases p38 and JNK ([@B80]; [@B79]; [@B78]). Following chemical inhibition of ERK1/2 signaling, but not that of p38 or JNK, we report a significant increase in the ratio of GJA1-20k to GJA1-43k. ERK1/2 signaling is necessary for TGF-β--induced EMT, further suggesting a role for internal translation of *GJA1* in EMT ([@B72]). Of relevance, ERK pathway activation promotes canonical translation through ribosomal protein S6 phosphorylation ([@B50]). Our findings are also consistent with previous reports that Mnk1/2 suppresses GJA1-20k translation as ERK activation is upstream of Mnk ([@B51]). We find inhibition of Smad3 activity with the inhibitor SIS3 also rescues GJA1-20k expression, implying transcriptional effects may also regulate *GJA1* translation, such as alternate UTR usage. However, our data in [Figure 1D](#F1){ref-type="fig"}, in which we overexpress the coding sequence of *GJA1* alone, support a dominant shift in cellular processes regulating translation initiation independent of changes to the mRNA. Moreover, internal translation of an independent mRNA transcript, *paxillin* (*Pxn*), has also been reported in EMT, suggesting a global shift in translation initiation during TGF-β--induced EMT ([@B66]). Given the role of paxillin in EMT through focal adhesion formation, it is tempting to speculate that an entire "nonjunctional" mesenchymal and motile phenotype may be affected through suppression of internal translation relevant mRNA families ([@B67]).

Direct posttranslational modification through phosphorylation of the GJA1-43k C-terminus is known to promote gap junction internalization and degradation of GJA1-43k ([@B19]; [@B60]; [@B61]). A phosphorylation cascade encompassing Akt, PKC, and MAPK converges at the GJA1-43k C-terminus to effect internalization from the plasma membrane ([@B60]). Indeed, alterations in GJA1-43k phosphoisoforms are observed in our biochemical solubility studies where we find reduced junctional GJA1-43k in mesenchymal cells. Together with our localization data and the fact that we report GJA1-43k is stabilized during TGF-β--induced EMT, however, it seems probable that GJA1-43k predominantly remains within intracellular compartments in these cells, the majority most likely not having reached the cell surface where such phosphorylation events are understood to occur. Moreover, the internalization of gap junctions occurs rapidly after activation of growth factor signaling cascades and so may play a role in dissolution of gap junctions earlier in the EMT process than the 48--72 h time points examined in this study ([@B12]; [@B15]; [@B60]).

Oligomerization of GJA1-43k into hemichannels occurs at the TGN, later in the vesicular transport pathway than most ion channels ([@B41]). Only two proteins are known to interact with GJA1-43k in the ER/Golgi and regulate its transport. ERP29 interacts with GJA1-43k within the ER preventing premature oligomerization, and the GTPase Rab20 can also regulate Cx43 transport from the ER ([@B10]; [@B9]). Previous findings demonstrated that GJA1-20k resides in the ER/Golgi, interacts with GJA1-43k, and regulates gap junction formation ([@B58]). Recently, GJA1-20k has been localized to the mitochondria, where immunogold electron microscopy revealed GJA1-20k at the microtubule/mitochondria interface in addition to ER/Golgi. Here, we have utilized confocal microscopy to confirm localization GJA1-20k to the Golgi apparatus. Therefore, GJA1-20k may complement ERP29/Rab20 activity by chaperoning GJA1-43k through the Golgi apparatus transport pathway, spatially and temporally regulating Cx43 hemichannel oligomerization and vesicular loading at the TGN. The stoichiometry of GJA1-43k/GJA1-20k is difficult to measure in the biochemical assays herein, but it does seem that relatively low levels of GJA1-20k are sufficient to promote GJA1-43k transport. Given that GJA1-20k has not been detected on the cell surface and resides primarily within the Golgi apparatus, it is likely that one GJA1-20k molecule may interact transiently with several GJA1-43k monomers/hemichannel intermediates as they pass through the Golgi apparatus.

As a membrane channel, Cx43 hemichannels can exchange molecules such as ATP and glutamate with the extracellular milieu in addition to its more established function as a gap junction ([@B63]; [@B43]). Although our biochemical Triton X-100 solubility findings demonstrate a relative reduction in Cx43 gap junction formation during EMT, they do not exclude the possibility of increased surface hemichannel expression. Accrual of surface Cx43 hemichannels into gap junction structures is limited by binding of the C-­terminus to ZO-1, a scaffolding protein down-regulated during TGF-β--induced EMT ([@B48]). Therefore, in mesenchymal cells we would expect the absence of negative regulation of gap junction accretion by ZO-1, but did not observe increases in gap junction size with TGF-β stimulation. Furthermore, data presented in [Figures 3](#F3){ref-type="fig"} and [6](#F6){ref-type="fig"} show that TGF-β stimulation alters Cx43 protein stability and oligomerization, which are key limiting steps in the trafficking of hemichannels to the cell surface. These findings, together with previous studies indicating GJA1-20k expression is restricted to intercellular compartments, lead us to conclude that the observed increases in soluble GJA1-43k is primarily intracellular. The role of Cx43 internally translated isoforms in regulation of surface hemichannel activity and/or accrual into gap junctions, however, is an interesting topic of future research.

Several internally translated isoforms of Cx43 have been detected in addition to GJA1-20k ([@B58]). In this study, we focus on GJA1-20k as the most predominantly expressed isoform but given that all three preceding methionine codons (M100, 125, and 147) must also be mutated to limit GJA1-43k trafficking, some redundancy in function is likely to exist between these molecules ([@B58]). The Cx43 C-terminal truncation mutant does not display perturbed trafficking ([@B14]; [@B40]; [@B34]), but would encode all four isoforms mentioned above also lacking their C-termini. Intriguingly, this may point toward the fourth transmembrane domain of Cx43, which is intact in this mutant and contained in GJA1-20k as most important in regulation of GJA1-43k transport. Together, our data indicate that levels of GJA1-20k provide a means for the cell to fine-tune Cx43 hemichannel oligomerization and thus gap junctions rapidly at the posttranscriptional level. Indeed, pathological Cx43 remodeling in the heart during ischemia can be prevented through actin stabilization by ectopic GJA1-20k expression, suggesting internal translation is a common pathway for gap junction regulation across diverse cell types and tissues ([@B1]).

At least 600 human genes are now understood to undergo alternate mechanisms of translation initiation and this study supports the importance of this biological process in health and disease ([@B23]; [@B71];, [@B26]). Regulation of translation initiation can be thought of globally, whereby signal transduction cascades can shunt the entire translational landscape of the cell, or gene-specifically, where alternate promoter usage/splicing can lead to changes in specific mRNAs and render them subject to such translation initiation. Our data reveal that a shift in the translational landscape of the cell occurs during EMT affecting the proteome and contributing to alterations in gap junction formation. This suggests a potent mechanism whereby the cell can rapidly regulate Cx43 transport and gap junction formation at the point of GJA1-20k translation, without inducing transcription of mRNA or synthesis of full-length GJA1-43k.

MATERIALS AND METHODS
=====================

Molecular biology
-----------------

Human *GJA1* cDNA was obtained from GE Dharmacon and cloned into pDONR221 using Gateway BP cloning (forward primer GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGTGGTGCCCAGGCAAC; reverse primer GGGGACCACTTTGTACAAGAAA­G­CTGGGTTCTAGATCTCCAGGTCATCAGGCC) to create an entry clone (BP clonase II; Thermo Scientific). *GJA1* was then inserted into pcDNA3.2-V5/DEST from pDONR221/hGJA1 entry clone using Gateway LR cloning to generate pcDNA3.2/hGJA1. pcDNA3.2/GJA1-20k-V5 was generated using forward primer GGGGACAAG TTTGTACAAAAA­AGCAGGCTTAA­TGCTGGTGGTGTCCTT­GGT and reverse primer GGGGACCAC­TTTGTACAAGAAA­GCTGGGTTG­ATCTCCAGGTCAT­CAGGCCG to insert the GJA1-20k coding sequence into pDONR221 using Gateway BP cloning (BP clonase II; Thermo Scientific). GJA1-20k was then inserted into pcDNA3.2/V5-DEST from pDON­R221/hGJA1-20k entry clone using Gateway LR cloning (LR clonase; Thermo Scientific). Lentiviral expression vectors were created using TOPO cloning to insert the *GJA1* coding sequence (forward primer GTGGTGCC­CAGGCAACATG; reverse primer CTAG­ATCTCCAGGTCATCA­GGCC) or GJA1-20k (forward primer ATGCTGGTGGTGTCCTTGGTG; reverse primer CTAGATCTCCAGGTCATCAGGCC) into pLenti6.3/V5-TOPO (Thermo Scientific). pLenti6.3/V5-GW/lacZ and pcDNA3.2/GW-CAT served as control expression vectors (Thermo Scientific). All recombinant DNA constructs were verified by Sanger sequencing.

Cell culture
------------

NMuMG cells were a kind gift from Rik Derynck (University of California, San Francisco) and maintained in DMEM+Glutamax supplemented with 10% fetal bovine serum (FBS), sodium pyruvate, nonessential amino acids (Thermo Scientific), bovine insulin solution (5 μg/ml; Sigma) and MycoZAP (Lonza). MycoZAP is included to prevent *Mycoplasma* contamination. Cells were maintained in a humidified atmosphere of 5% CO~2~ at 37°C. For experiments, cells were plated at 1.6 × 10^4^ cells/cm^2^ in 100-mm plates or six-well dishes for protein harvesting and eight-well chamber slides for imaging. Cells were incubated for 24 h before addition of media containing one of the following treatments: TGF-β1 (2 ng/ml; Humanzyme), the TβR1 blocker SB 431542 (SB; 5 µM; Sigma), Smad3 inhibitor SIS3 (10 µM; Selleckchem), p38 inhibitor SB 202190 (20 µM; Cayman), JNK inhibitor SP 600125 (20 µM; Cayman), ERK1/2 inhibitor SCH 772984 (0.1 µM; Cayman), or vehicle (veh; dimethyl sulfoxide \[DMSO\]). 293FT cells were obtained from Thermo Scientific and maintained in DMEM+GlutaMAX supplemented with 10% FBS, sodium pyruvate, nonessential amino acids (Thermo Scientific), and MycoZAP (Lonza).

Lentivirus production, cell transduction, and stable cell line generation
-------------------------------------------------------------------------

Lentivirus was created from pLenti6.3-h*GJA1*, pLenti6.3/GJA1-20k, and pLenti6.3-*LacZ* according to the manufacturer's instructions (ViraPower Lentiviral Expression System; Thermo Scientific). Titered and normalized viruses were used to infect NMuMG cells plated in six-well dishes in the presence of hexadimethrine bromide (4 µg/ml; Sigma). After 48 h, cells were split 1:40 into 100-mm dishes and 10 µg/ml blasticidin added to medium for selection. Medium was changed every 2 d and healthy colonies picked using cloning rings (Scienceware). Clones were expanded and screened for stable expression by Western blotting and immunofluorescence.

Western blotting
----------------

Cells were lysed in RIPA buffer (0.1% SDS, 50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 2 mM NaF, 200 μM Na~3~VO~4~) supplemented with HALT Protease and Phosphatase Inhibitor Cocktail (Thermo Scientific) and Western blotting conducted as previously described ([@B57], [@B59]). Briefly, cells were scraped into RIPA buffer and sonicated before centrifugation at 10,000 × *g* for 20 min at 4°C. Protein concentration was quantified using the Bio-Rad DC Protein Assay and lysates normalized to the same concentration. 4X Bolt LDS sample buffer (Thermo Scientific) supplemented with dithiothreitol (DTT; 400 mM) was added and samples heated for 10 min at 70°C before SDS--PAGE and Western blotting with the following primary antibodies: mouse anti--N-cadherin and mouse anti--E-cadherin (1:1000; BD Biosciences), rabbit anti-Cx43 (1:3000; Sigma), rabbit anti-fibronectin (1:3000; Sigma), and mouse anti--α-tubulin (1:3000; Sigma). Goat secondary antibodies conjugated to Alexa Fluor 555 and 647 (Thermo Scientific) were used at 1:1000 and membranes imaged on a ChemiDoc MP (Bio-Rad).

Immunofluorescence
------------------

Cells were fixed in 37°C 4% paraformaldehyde for 20 min and stored in PBS at 4°C until immunostaining was conducted as previously described ([@B59]) with the following primary antibodies: rabbit anti-fibronectin (Sigma; 1:500), mouse anti--N-cadherin (BD Biosciences; 1:200), mouse anti--E-cadherin (BD Biosciences; 1:1000), rabbit anti-Cx43 (Sigma; 1:3000), and mouse anti--α-tubulin (Sigma; 1:3000). Secondary antibodies used were goat anti-rabbit Alexa Fluor 488 and anti-mouse Alexa Fluor 647 (Thermo Scientific; 1:500) with Alexa Fluor 647 phalloidin employed to detect actin (Thermo Scientific; 1:20). For immunofluorescence using antibody directed against the Cx43 cytoplasmic loop, cells grown on 35-mm glass-bottomed dishes (Mat-Tek) or eight-well chambered slides were fixed in methanol for 5 min on ice. Antibodies used were rabbit anti-Cx43 cytoplasmic loop (Abcam; 1:500), mouse anti-pan cadherin (BD Biosciences; 1:500), and anti-rabbit Alexa Fluor 488 and anti-mouse Alexa Fluor 647 (ThermoScientific; 1:500). To localize GJA1-20k, NMuMG cells were transfected in 35-mm glass-bottomed dishes with 2 µg pcDNA3.2/hGJA1-20k-V5, or pcDNA3.2/GW-CAT using Lipofectamine 3000 (Thermo Scientific). Posttransfection (24 h) cells were fixed in methanol for 5 min on ice. Immunostaining was performed as described above using the following primary antibodies: rabbit anti-V5 (Sigma; 1:1000) and mouse anti-GM130 (BD Biosciences; 1:250).

Superresolution microscopy
--------------------------

Cells plated in 35-mm Mat-Tek dishes were fixed in methanol for 5 min on ice. Cells were washed three times in PBS before blocking for 1 h at room temperature in 5% normal donkey serum (Jackson ImmunoResearch), 0.5% Triton X-100, in PBS (blocking buffer). Cells were incubated with the following primary antibodies diluted in blocking buffer: mouse anti-GM130 (BD Biosciences; 1:1000) and rabbit anti-Cx43 cytoplasmic loop (Abcam,; 1:500). Following PBS washes, cells were incubated with donkey secondary antibodies conjugated to Alexa Fluor 647 (Thermo Scientific) or CF568 (Biotium) diluted in blocking buffer. After PBS washes, two-color direct STORM imaging was conducted using a Vutara 350 (Bruker). Cells were imaged in 50 mM Tris-HCl, 10 mM NaCl, 10% (wt/vol) glucose buffer containing 20 mM mercaptoethylamine, 1% (vol/vol) 2-mercaptoethanol, 168 active units/ml glucose oxidase, and 1404 active units/ml catalase. Videos of 5000 frames were acquired for each probe and three-dimensional (3D) images reconstructed in Vutara SRX software. Intracellular regions of interest were selected and coordinates of localized molecules used to calculate pair correlation functions in the Vutara SRX software ([@B55], [@B54]).

Image analysis
--------------

For quantification of Cx43 expression at cell--cell borders, pan-cadherin images were used to identify cell--cell borders for vehicle and TGF-β--treated cells, respectively. Lines (10 µm) were drawn perpendicular to cell--cell borders every 10 pixels for the length of each border. The plot profile function in ImageJ was used to quantify Cx43 fluorescence intensity from each line and data averaged. Images were acquired and analyzed by separate individuals, with image identity blinded to the analyst.

Separation of soluble (nonjunctional) and insoluble (junctional) Cx43
---------------------------------------------------------------------

Cells were harvested in 1% Triton X-100 buffer (50 mM Tris, pH 7.4, 1% Triton X-100, 2 mM EDTA, 2 mM ethylene glycol-bis(β-aminoethyl ether)-*N*,*N*,*N*',*N*'-tetraacetic acid \[EGTA\], 250 mM NaCl, 1 mM NaF, 0.1 mM Na~3~VO~4~) supplemented with HALT Protease and Phosphatase Inhibitor Cocktail (Thermo Scientific). Samples were lysed in 1% Triton X-100 buffer for 1 h nutating at 4°C. After lysing, 25 µl of lysate was removed and snap-frozen to serve as total protein fraction. The remaining lysate was centrifuged at 15,000 × *g* for 30 min, and supernatant removed to serve as the soluble fraction. Pellets containing insoluble protein were resuspended in 4X Bolt LDS sample buffer (Thermo Scientific). All samples were sonicated and centrifuged for 20 min at 10,000 × *g* following the addition of 4X Bolt LDS sample buffer (Thermo Scientific) supplemented with DTT (400 mM) and SDS--PAGE Western blotting performed as described above.

Real-time quantitative PCR
--------------------------

RNA was extracted from NMuMG cells using the Purelink RNA Mini Kit (Thermo Scientific) and homogenized by passage 10 times through an 18-gauge needle. DNA was digested on column using PureLink DNase (Thermo Scientific). RNA (1 µg) was reverse transcribed with iScript cDNA Synthesis Kit (Bio-Rad). RT-qPCR was performed using SYBR Select Master Mix for CFX (Thermo Scientific) on a CFX Connect Real-Time System (Bio-Rad). Validated PrimeTime qPCR primers were purchased from Integrated DNA Technologies. Cycling parameters consisted of 50°C, 2 min; 95°C, 2 min; 39 cycles of 95°C, 15 s; 55°C, 15 s; 72°C, 1 min followed by a melt curve.

Click chemistry pulse-chase assay
---------------------------------

NMuMG cells were plated in six-well dishes and fully supplemented DMEM and treated with TGF-β or vehicle as described above. After 48 h TGF-β stimulation, cells were rinsed and starved for 1 h in methionine/cysteine-free DMEM (Thermo Scientific) supplemented with 10% dialyzed FBS (GE Healthcare). Cells were then pulsed for 1 h with Click-iT L-Azidohomoalanine (ThermoScientific; 50 µM final concentration) added directly to starvation media. Samples were harvested over an 8 h period at 2 h intervals into 200 μl lysis buffer (1% SDS, 50 mM Tris-HCl) supplemented with HALT Protease and Phosphatase Inhibitor Cocktail (Thermo Scientific). Lysates were incubated on ice for 15 min and sonicated before centrifugation at 10,000 × *g* for 20 min at 4°C. Protein concentration was quantified using the Bio-Rad DC Protein Assay and all samples normalized to 400 µg/100 µl. The click reaction was performed on 400 µg protein using the Click-iT Protein Reaction Buffer Kit and tetramethylrhodamine (TAMRA) alkyne (ThermoScientific; 40 µM final concentration) as per manufacturer's instructions. Immunoprecipitation was performed as previously described ([@B60]). Briefly, Cx43 was immunoprecipitated from precleared lysates using 1 µg rabbit anti-Cx43 (Sigma) and protein G Dynabeads (Thermo Scientific). Western blotting was performed as described above and pulsed Cx43 detected using antibody directed against TAMRA (ThermoScientific; 1:1000). Blots were stripped using Re-Blot Plus Strong Solution (Millipore) and reprobed for total Cx43 with rabbit anti-Cx43 (Sigma; 1:3000).

Blue NativePAGE
---------------

NMuMG cells were washed twice with PBS and harvested by scraping into 1X NativePAGE sample buffer (Thermo Scientific) containing 1% Digitonin and HALT Protease Inhibitor Cocktail (Thermo Scientific). Lysates were centrifuged at 100,000 × *g* for 15 min at 4°C using a Beckman Coulter Optima TLX ultracentrifuge. G-250 sample additive was added to supernatants to 0.25%. Samples were loaded on a 4--16% Bis-Tris Novex NativePAGE Gel (Thermo Scientific) and electrophoresed at 4°C according to the manufacturer's instructions. Proteins were transferred to PVDF membranes in Bolt transfer buffer (Thermo Scientific) for 1 h at 25 V. GJA1-43k was detected with rabbit anti-Cx43 (Sigma; 1:3000) followed by goat anti-rabbit horseradish peroxidase (HRP) (Abcam; 1:5000). Membranes were imaged following the addition of Clarity Western ECL Substrate on a ChemiDoc MP (Bio-Rad).
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Cx43

:   connexin 43

EMT

:   epithelial--mesenchymal transition

IRES

:   internal ribosome entry site

mTOR

:   mammalian target of rapamycin

ORF

:   open reading frame

TGF-β

:   transforming growth factor beta
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:   *trans*-Golgi network

UTR
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